SRI-81 Shatavari Receives Health Canada Natural Product License

CK Nutraceuticals, the exclusive Canadian distributor of Ixoreal Biomed’s SRI-81 Shatavari, announced that the ingredient has been issued a Natural Product Number (NPN80149608) by Health Canada.

The product license authorizes several health claims for SRI-81, including:

• Helps manage menopausal symptoms.
• Helps relieve vasomotor symptoms in perimenopausal owmen, such as hot flashes and night sweats.
• Helps reduce menopausal symptoms such as anxiety, irritability, and fatigue.
• Helps relieve symptoms of menopause to support and maintain overall well-being and quality of life in women.
• Helps support healthy sexual arousal and satisfaction in women.

SRI-81 Shatavari is the latest offering from Ixoreal; its KSM-66 Ashwagandha has 14 Health Canada claims approvals. SRI-81 is a proprietary shatavari root extract clinically studied for women’s health, menopause support, and sexual wellness. The ingredient is standardized to shatavarin IV and total shatavarins.

“The Health Canada approval represents an important milestone for SRI-81 Shatavari and provides Canadian supplement brands with a compliant pathway to formulate innovative women’s health products backed by both clinical research and regulatory approval,” said Colleen Madden, VP of innovation at CK Nutraceuticals.